SCHEDULE 13G/A//SEC Filing
Lyell Immunopharma, Inc. SCHEDULE 13G/A
Accession 0001104659-25-049403
CIK 0001704131other
Filed
May 14, 8:00 PM ET
Accepted
May 15, 4:04 PM ET
Size
22.9 KB
Accession
0001104659-25-049403
Documents
Issuer
Foresite Capital Fund IV, L.P.
CIK 0001704131
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001704131
Filing Metadata
- Form type
- SCHEDULE 13G/A
- Filed
- May 14, 8:00 PM ET
- Accepted
- May 15, 4:04 PM ET
- Size
- 22.9 KB